Limba
Romanian
Romanian
English|
CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2activation with an IC50 of 0.58 ± 0.09 µM while no significant inhibition to TLR2/6. It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4).
| Price | 992,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
CU-CPT22 shows dose-dependent inhibitory effects blocking Pam3CSK4-induced TLR1/2activation with an IC50 of 0.58 ± 0.09 µM while no significant inhibition to TLR2/6. It demonstrates minimal non-specific inhibition against a panel of 10 representative kinases (PDGFRB, MET, DDR2, SRC, MAPK1, PAK1, AKT1, PKC-γ, CAMK1, and PLK4). |
